Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 02, 2023

SELL
$0.79 - $1.91 $4,769 - $11,530
-6,037 Reduced 18.91%
25,895 $21,000
Q3 2022

Nov 09, 2022

BUY
$1.66 - $2.79 $7,899 - $13,277
4,759 Added 17.51%
31,932 $55,000
Q2 2022

Aug 15, 2022

BUY
$1.44 - $3.98 $3,283 - $9,074
2,280 Added 9.16%
27,173 $47,000
Q1 2022

Jun 30, 2022

SELL
$2.97 - $5.2 $5,672 - $9,932
-1,910 Reduced 7.13%
24,893 $89,000
Q4 2021

Feb 15, 2022

SELL
$4.99 - $7.46 $1,222 - $1,827
-245 Reduced 0.91%
26,803 $134,000
Q3 2021

Oct 29, 2021

SELL
$7.16 - $9.69 $14,262 - $19,302
-1,992 Reduced 6.86%
27,048 $194,000
Q2 2021

Aug 16, 2021

BUY
$6.23 - $10.03 $18,197 - $29,297
2,921 Added 11.18%
29,040 $269,000
Q1 2021

May 13, 2021

BUY
$8.81 - $16.96 $11,955 - $23,014
1,357 Added 5.48%
26,119 $242,000
Q4 2020

Feb 12, 2021

BUY
$8.5 - $12.85 $3,272 - $4,947
385 Added 1.58%
24,762 $219,000
Q3 2020

Oct 30, 2020

BUY
$9.57 - $27.05 $12,976 - $36,679
1,356 Added 5.89%
24,377 $283,000
Q2 2020

Aug 10, 2020

BUY
$7.14 - $31.69 $46,202 - $205,065
6,471 Added 39.1%
23,021 $620,000
Q1 2020

May 13, 2020

BUY
$2.98 - $14.09 $1,028 - $4,861
345 Added 2.13%
16,550 $123,000
Q3 2019

Nov 13, 2019

SELL
$2.05 - $3.02 $278 - $410
-136 Reduced 0.83%
16,205 $33,000
Q2 2019

Aug 14, 2019

BUY
$2.29 - $4.1 $8,053 - $14,419
3,517 Added 27.43%
16,341 $48,000
Q1 2019

May 15, 2019

BUY
$3.34 - $5.1 $1,476 - $2,254
442 Added 3.57%
12,824 $48,000
Q4 2018

Feb 15, 2019

BUY
$3.89 - $6.11 $48,165 - $75,654
12,382 New
12,382 $50,000
Q3 2018

Nov 14, 2018

SELL
$3.92 - $5.58 $49,415 - $70,341
-12,606 Closed
0 $0
Q2 2018

Jul 18, 2018

BUY
$3.88 - $5.16 $6,429 - $8,550
1,657 Added 15.13%
12,606 $49,000
Q1 2018

May 22, 2018

SELL
$4.05 - $5.69 $652 - $916
-161 Reduced 1.45%
10,949 $52,000
Q4 2017

Feb 13, 2018

BUY
$4.13 - $6.68 $2,862 - $4,629
693 Added 6.65%
11,110 $46,000
Q3 2017

Nov 09, 2017

BUY
$5.36 - $6.37 $55,835 - $66,356
10,417
10,417 $66,000

Others Institutions Holding INO

About INOVIO PHARMACEUTICALS, INC.


  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $566M
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.